2006/034 New NICE guidance to help sufferers of psoriasis and psoriatic arthritis
The National Institute for Health and Care Excellence (NICE) has today (Wednesday 26 July) launched guidance on the use within the NHS in England and Wales of etanercept and efalizumab for the treatment of psoriasis, and etanercept and infliximab for the treatment of psoriatic arthritis (PsA).
- Technology appraisal on psoriasis - efalizumab and etanercept
- Technology appraisal on psoriatic arthritis - etanercept and infliximab
|2006/034 New NICE guidance to help sufferers of psoriasis and psoriatic arthritis
26 July 2006
(47.2Kb 16sec @ 28.8Kbps)
This page was last updated: 03 July 2009